FREEDOM HOLDINGS (FHLD) SHAREHOLDER UPDATE; 15c211 Nears Final Approval from FINRA
- None.
- None.
CHATSWORTH, CA / ACCESSWIRE / December 8, 2023 / Freedom Holdings, Inc. aka Freedom Acquisition Corp. (OTC PINK:FHLD) ("FHLD" or the "Company") is pleased to announce following Company Update: Freedom Holdings waiting on 15c211 final approval from FINRA.
This past summer, Freedom Holdings had worked diligently with a Glendale Securities over the past several months to seek FINRA approval of its 15C-211. We expect having that approval any day now. This will give us the opportunity to continue to explore additional funding opportunities. Glendale Securities, to file it's 15c211 with FINRA. After answering all FINRA's comments, Freedom Holdings nears final approval of its 15c211 to bring the company from current audited fully reporting Pink Sheet, to OTCQB.
John Vivian, Freedom Holdings CEO, stated: "The company has worked diligently with FINRA over the past several months to seek approval of it's 15c211. We expect having that approval any day now.
The past couple of months, the company has been in talks with institutions and investors who have shown interest in making an investment in Freedom Holdings. Our commitment to our shareholders is to procure value while providing great returns.
Our current focused efforts have been on acquiring profitable cannabis-based businesses along with exploring possible, joint venture partnership opportunities".
As the new year approaches, the company plans to purchase a new facility to Extract, Manufacture, Grow and Test all our cannabis products within our own Facility.
The Company's medical cannabis, division (MCD), expects to begin the FDA - Clinical Trials to treat cancer Pain in mid-February. Based on the fact 100's of companies have started clinical trials for cannabis, phase one "safety" is already done and registered. This gives Freedom Holdings a clear advantage for an early and quicker completion. We are preparing to set up Equipment to extract the THC cannabinoids that help the pain due to cancer. Once we acquire our facility, we will be able to install the Equipment in three days and begin Extraction.
What makes Freedom Holdings unique is our ability to adapt and pivot in today's evolving markets. We are currently working hard and look forward to sharing future developments as they materialize. Freedom Holdings wants to wish everyone a safe and happy holiday season.
Press Release Contact:
John Vivian
Freedom Holdings, Inc.
818-357-3185
Safe Harbor Statement
This press release contains statements which may constitute forward-looking statements within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief, or current expectations of the Company, members of its management, and assumptions on which such statements are based. We caution prospective investors that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties and that actual results may differ materially from those contemplated by such forward-looking statements.
SOURCE: FREEDOM HLDG INC.
via PRISM Mediawire, LLC
View the original press release on accesswire.com
FAQ
What is the current status of Freedom Holdings' 15c211 approval from FINRA?
What are the company's plans after obtaining the 15c211 approval?
What are Freedom Holdings' plans for its cannabis products?
When does the medical cannabis division expect to begin FDA clinical trials?
What sets Freedom Holdings apart in the market?
